학술논문
311P Pooled-analysis of prospective observational studies evaluated the effectiveness and safety of bevacizumab and paclitaxel as the first-line chemotherapy for HER2-negative metastatic breast cancer
Document Type
Abstract
Author
Source
In Annals of Oncology September 2020 31 Supplement 4:S367-S367
Subject
Language
ISSN
0923-7534